https://travere.com/wp-content/uploads/Retrophin_SoloMark_FullColor_RGB-300-1.png200200superadminhttps://travere.com/wp-content/uploads/Travere-TxTM_Inline-fullcolor.pngsuperadmin2021-03-02 15:38:572021-03-02 15:42:05Travere Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
SAN DIEGO, Feb. 25, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) will join the National Organization for Rare Disorders (NORD), the European Organisation for Rare Diseases (EURORDIS), EveryLife Foundation for Rare Diseases, Global Genes, and rare disease advocates and patients worldwide in recognizing February 28 as Rare Disease Day 2021.
https://travere.com/wp-content/uploads/Retrophin_SoloMark_FullColor_RGB-300-1.png200200superadminhttps://travere.com/wp-content/uploads/Travere-TxTM_Inline-fullcolor.pngsuperadmin2021-02-25 05:35:122021-02-25 06:00:00Travere Therapeutics Recognizes Rare Disease Day 2021 and the Importance of Working Together to Innovate and Address Healthcare Disparities in Rare Disease
On February 23, 2021, the Black Women’s Health Imperative (BWHI) held the first public meeting of the Rare Disease Diversity Coalition (RDDC) with more than 200 rare disease community members joining together to endorse an ambitious platform of 10 initiatives to achieve tangible solutions to address issues, including delays in diagnosis and treatment for diverse patients. We’re proud to work closely with the leaders of the BWHI to spearhead the formation of the RDDC.
https://travere.com/wp-content/uploads/RDDC-Feb23.png362641superadminhttps://travere.com/wp-content/uploads/Travere-TxTM_Inline-fullcolor.pngsuperadmin2021-02-23 15:41:212021-02-23 17:16:43Rare Disease Diversity Coalition Formed To End Racial Disparities In Rare Disease Diagnosis, Research And Treatment
On February 23, 2021, the nonprofit organization RARE-X announced plans to expand its work helping patient groups collect structured, standardized research-ready data that will better support the development of future treatments. This foundational work is made possible through a funding commitment from Travere Therapeutics.
https://travere.com/wp-content/uploads/RareXLogo_F_desktop.jpg65181superadminhttps://travere.com/wp-content/uploads/Travere-TxTM_Inline-fullcolor.pngsuperadmin2021-02-23 15:26:162021-02-23 17:20:24RARE-X Announces Patient Community Data Collection, Sharing, and Platform Enhancements with Support from Travere
https://travere.com/wp-content/uploads/delila.jpg1280960superadminhttps://travere.com/wp-content/uploads/Travere-TxTM_Inline-fullcolor.pngsuperadmin2021-02-14 09:00:552021-02-16 14:24:17Meet Delila – Living with Alagille Syndrome